Adjunctive balloon dilatation after stent deployment: Beneficial or deleterious?

International Journal of Cardiology

Volumn 157, Issue 1, 2012, Pages 3-7

  Biswas, Sinjini ^a   Soon, Kean ^a   Lim, Yean L ^a  

^a WESTERN HOSPITAL   (Australia)

Author keywords

Angioplasty; Apposition; Coronary; Postdilatation; Stent underexpansion; Stenting

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY DISSECTION; BALLOON DILATATION; BARE METAL STENT; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CORONARY ARTERY CALCIFICATION; CORONARY ARTERY DISEASE; CORONARY ARTERY PERFORATION; CORONARY ARTERY RECANALIZATION; CORONARY STENT; DRUG ELUTING STENT; HUMAN; IATROGENIC DISEASE; IN-STENT RESTENOSIS; INTRAVASCULAR ULTRASOUND; NEOINTIMA; NO REFLOW PHENOMENON; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS;

ANIMALS; CATHETERIZATION; CORONARY ARTERY DISEASE; HUMANS; MYOCARDIAL INFARCTION; STENTS;

EID: 84860243532     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.011     Document Type: Review

References (41)

1. Y. Honda, P. Fitzgerald, and P. Yock Intravascular ultrasound E. Topol, Textbook of interventional cardiology 4th ed. 2003 Elsevier Science Philadelphia 893 917
2. S. Rathore, M. Terashima, and M. Habara Incomplete stent apposition after coronary stent implantation: myth or reality? J Interv Cardiol 22 2009 341 349
3. Y. Takano, L.A. Yeatman, and J.R. Higgins Optimizing stent expansion with new stent delivery systems J Am Coll Cardiol 38 2001 1622 1627
4. B.R. Brodie, C. Cooper, M. Jones, P. Fitzgerald, and F. Cummins Is adjunctive balloon postdilatation necessary after coronary stent deployment? Final results from the POSTIT trial Catheter Cardiovasc Interv 59 2003 184 192
5. J. de Ribamar Costa Jr., G.S. Mintz, and S.G. Carlier Intravascular ultrasonic assessment of stent diameters derived from manufacturer's compliance charts Am J Cardiol 96 2005 74 78
6. J. de Ribamar Costa Jr., G.S. Mintz, and S.G. Carlier Intravascular ultrasound assessment of drug-eluting stent expansion Am Heart J 153 2007 297 303
7. S. Sonoda, Y. Morino, and J. Ako Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial J Am Coll Cardiol 43 2004 1959 1963
8. C. Briguori, J. Tobis, and T. Nishida Discrepancy between angiography and intravascular ultrasound when analysing small coronary arteries Eur Heart J 23 2002 247 254
9. E. Romagnoli, G.M. Sangiorgi, J. Cosgrave, E. Guillet, and A. Colombo Drug-eluting stenting: the case for post-dilation JACC Cardiovasc Interv 1 2008 22 31
10. R. Hoffmann, G.S. Mintz, and R. Mehran Intravascular ultrasound predictors of angiographic restenosis in lesions treated with Palmaz-Schatz stents J Am Coll Cardiol 31 1998 43 49
11. S. Kasaoka, J.M. Tobis, and T. Akiyama Angiographic and intravascular ultrasound predictors of in-stent restenosis J Am Coll Cardiol 32 1998 1630 1635
12. M. Vavuranakis, K. Toutouzas, C. Stefanadis, C. Chrisohou, D. Markou, and P. Toutouzas Stent deployment in calcified lesions: can we overcome calcific restraint with high-pressure balloon inflations? Catheter Cardiovasc Interv 52 2001 164 172
13. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA. 293 2005 2126 2130
14. N.G. Uren, S.P. Schwarzacher, and J.A. Metz Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry Eur Heart J 23 2002 124 132
15. E. Cheneau, L. Leborgne, and G.S. Mintz Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study Circulation 108 2003 43 47
16. K. Fujii, S.G. Carlier, and G.S. Mintz Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study J Am Coll Cardiol 45 2005 995 998
17. R.J. Russo, M.J. Attubato, and C.J. Davidson Angiography versus intravascular ultrasound-directed stent placement: final results from AVID Circulation 100 1999
18. S. Aziz, J.L. Morris, R.A. Perry, and R.H. Stables Postdilatation following coronary stent deployment: lesion and procedural characteristics associated with an increase in stent dimensions J Invasive Cardiol 20 2008 342 346
19. Z. Gao, Y.J. Yang, and B. Xu Is adjunctive balloon postdilatation necessary with drug-eluting stents? One center experience in Chinese patients Chin Med J (Engl). 121 2008 513 517
20. K. Tanabe, P.W. Serruys, and M. Degertekin Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial Circulation 111 2005 900 905
21. Y.S. Kim, B.K. Koo, and J.B. Seo The incidence and predictors of postprocedural incomplete stent apposition after angiographically successful drug-eluting stent implantation Catheter Cardiovasc Interv 74 2009 58 63
22. B.L. van der Hoeven, S.S. Liem, and J. Dijkstra Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study JACC Cardiovasc Interv 1 2008 192 201
23. M. Kimura, G.S. Mintz, and S. Carlier Outcome after acute incomplete sirolimus-eluting stent apposition as assessed by serial intravascular ultrasound Am J Cardiol 98 2006 436 442
24. A.V. Finn, G. Nakazawa, E. Ladich, F.D. Kolodgie, and R. Virmani Does underlying plaque morphology play a role in vessel healing after drug-eluting stent implantation? JACC Cardiovasc Imaging 1 2008 485 488
25. A.V. Finn, G. Nakazawa, and M. Joner Vascular responses to drug eluting stents: importance of delayed healing Arterioscler Thromb Vasc Biol 27 2007 1500 1510
26. C.W. Hwang, D. Wu, and E.R. Edelman Physiological transport forces govern drug distribution for stent-based delivery Circulation 104 2001 600 605
27. H. Takebayashi, G.S. Mintz, and S.G. Carlier Nonuniform strut distribution correlates with more neointimal hyperplasia after sirolimus-eluting stent implantation Circulation 110 2004 3430 3434
28. D.H. Steinberg, G.S. Mintz, and L. Mandinov Long-term impact of routinely detected early and late incomplete stent apposition: an integrated intravascular ultrasound analysis of the TAXUS IV, V, and VI and TAXUS ATLAS workhorse, long lesion, and direct stent studies JACC Cardiovasc Interv 3 2010 486 494
29. J. Tanigawa, P. Barlis, K. Dimopoulos, M. Dalby, P. Moore, and C. Di Mario The influence of strut thickness and cell design on immediate apposition of drug-eluting stents assessed by optical coherence tomography Int J Cardiol 134 2009 180 188
30. M.K. Hong, G.S. Mintz, and C.W. Lee Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation Circulation 109 2004 881 886
31. S.H. Hur, K. Kitamura, and Y. Morino Efficacy of postdeployment balloon dilatation for current generation stents as assessed by intravascular ultrasound Am J Cardiol 88 2001 1114 1119
32. R. Hoffmann, G. Guagliumi, and G. Musumeci Vascular response to sirolimus-eluting stents delivered with a nonaggressive implantation technique: comparison of intravascular ultrasound results from the multicenter, randomized E-SIRIUS, and SIRIUS trials Catheter Cardiovasc Interv 66 2005 499 506
33. D. Albrecht, S. Kaspers, R. Fussl, H.W. Hopp, and U. Sechtem Coronary plaque morphology affects stent deployment: assessment by intracoronary ultrasound Cathet Cardiovasc Diagn 38 1996 229 235
34. J. Schofer, M. Schluter, and A.H. Gershlick Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS) Lancet 362 2003 1093 1099
35. B.R. Brodie Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents? J Interv Cardiol 19 2006 43 50
36. R. Sakhuja, and L. Mauri Controversies in the use of drug-eluting stents for acute myocardial infarction: a critical appraisal of the data Annu Rev Med 61 2010 215 231
37. L.O. Jensen, M. Maeng, and P. Thayssen Clinical outcome after primary percutaneous coronary intervention with drug-eluting and bare metal stents in patients with ST-segment elevation myocardial infarction Circ Cardiovasc Interv 1 2008 176 184
38. R. Iijima, H. Shinji, and N. Ikeda Comparison of coronary arterial finding by intravascular ultrasound in patients with "transient no-reflow" versus "reflow" during percutaneous coronary intervention in acute coronary syndrome Am J Cardiol 97 2006 29 33
39. D. Brosh, A.R. Assali, and A. Mager Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality Am J Cardiol 99 2007 442 445
40. F.S. Resnic, M. Wainstein, and M.K. Lee No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention Am Heart J 145 2003 42 46
41. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2